These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 37495108

  • 1. Epstein-Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1.
    Wu Y, Zhang X, Liu C, Li Z, Wen Y, Zheng R, Xu C, Tian J, Wei L, Wang J, Yan Q, Zheng X, Ma J.
    J Biol Chem; 2023 Sep; 299(9):105082. PubMed ID: 37495108
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr Virus miRNA BART2-5p Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing RND3.
    Jiang C, Li L, Xiang YQ, Lung ML, Zeng T, Lu J, Tsao SW, Zeng MS, Yun JP, Kwong DLW, Guan XY.
    Cancer Res; 2020 May 15; 80(10):1957-1969. PubMed ID: 32060148
    [Abstract] [Full Text] [Related]

  • 3. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma.
    Lung RW, Hau PM, Yu KH, Yip KY, Tong JH, Chak WP, Chan AW, Lam KH, Lo AK, Tin EK, Chau SL, Pang JC, Kwan JS, Busson P, Young LS, Yap LF, Tsao SW, To KF, Lo KW.
    J Pathol; 2018 Apr 15; 244(4):394-407. PubMed ID: 29230817
    [Abstract] [Full Text] [Related]

  • 4. Effects of Dicer1 targeted by EBV-miR-BART6-5p on biological properties and radiosensitivity of nasopharyngeal carcinoma.
    Tang J, Liu ZY, Tang Y, Wang Y.
    Hum Exp Toxicol; 2021 Jun 15; 40(6):977-993. PubMed ID: 33305599
    [Abstract] [Full Text] [Related]

  • 5. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C, Zong J, Lin W, Wang M, Xu Y, Zhou R, Lin S, Guo Q, Chen H, Ye Y, Zhang B, Pan J.
    J Exp Clin Cancer Res; 2018 Nov 26; 37(1):283. PubMed ID: 30477559
    [Abstract] [Full Text] [Related]

  • 6. LncRNA BC200 promotes the development of EBV-associated nasopharyngeal carcinoma by competitively binding to miR-6834-5p to upregulate TYMS expression.
    Zhang S, Liu N, Cao P, Qin Q, Li J, Yang L, Xin Y, Jiang M, Zhang S, Yang J, Lu J.
    Int J Biol Macromol; 2024 Oct 26; 278(Pt 4):134837. PubMed ID: 39179085
    [Abstract] [Full Text] [Related]

  • 7. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ, Tong S, Zhang G, Zong J, Chen Y, Jin DY, Chen MR, Pan J, Chen H.
    J Virol; 2016 Jul 15; 90(14):6475-88. PubMed ID: 27147748
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.
    Zheng XH, Lu LX, Cui C, Chen MY, Li XZ, Jia WH.
    Oncotarget; 2016 Jan 26; 7(4):4972-80. PubMed ID: 26701721
    [Abstract] [Full Text] [Related]

  • 9. Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma.
    Gao W, Wong TS, Lv KX, Zhang MJ, Tsang RK, Chan JY.
    Head Neck; 2019 Mar 26; 41(3):780-792. PubMed ID: 30548946
    [Abstract] [Full Text] [Related]

  • 10. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
    Zhang G, Zong J, Lin S, Verhoeven RJ, Tong S, Chen Y, Ji M, Cheng W, Tsao SW, Lung M, Pan J, Chen H.
    Int J Cancer; 2015 Mar 01; 136(5):E301-12. PubMed ID: 25213622
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus-encoded microRNA BART22 serves as novel biomarkers and drives malignant transformation of nasopharyngeal carcinoma.
    Zhang T, Chen Z, Deng J, Xu K, Che D, Lin J, Jiang P, Gu X, Xu B.
    Cell Death Dis; 2022 Jul 30; 13(7):664. PubMed ID: 35907914
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
    Jiang C, Chen J, Xie S, Zhang L, Xiang Y, Lung M, Kam NW, Kwong DL, Cao S, Guan XY.
    Int J Cancer; 2018 Dec 15; 143(12):3209-3217. PubMed ID: 29971780
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
    Yan Q, Zeng Z, Gong Z, Zhang W, Li X, He B, Song Y, Li Q, Zeng Y, Liao Q, Chen P, Shi L, Fan S, Xiang B, Ma J, Zhou M, Li X, Yang J, Xiong W, Li G.
    Oncotarget; 2015 Dec 08; 6(39):41766-82. PubMed ID: 26497204
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus miR-BART2-5p and miR-BART11-5p regulate cell proliferation, apoptosis, and migration by targeting RB and p21 in gastric carcinoma.
    Zhao MH, Liu W, Zhang X, Zhang Y, Luo B.
    J Med Virol; 2023 Jan 08; 95(1):e28338. PubMed ID: 36418188
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway.
    Xu YJ, Zhou R, Zong JF, Lin WS, Tong S, Guo QJ, Lin C, Lin SJ, Chen YX, Chen MR, Chen HL, Ye YB, Pan JJ.
    Cancer Lett; 2019 Apr 10; 447():33-40. PubMed ID: 30684592
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.